Cancer Communications

Article	Citations
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020	513
Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020	475
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021	378
Ferroptosis in cancer and cancer immunotherapy	276
Non‐small cell lung cancer in China	213
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance	187
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma	177
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review	142
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy	136
A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors	128
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer	126
Breast cancer: an up‐to‐date review and future perspectives	126
New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer	121
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine	99
Advancing to the era of cancer immunotherapy	99
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase	97
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression	92
Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma	89
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities	86
Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art	81
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	79
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy	75
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma	74
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential	72
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy	67

New insights into molecules and pathways of cancer metabolism and therapeutic implications	66
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	65
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment	65
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA	62
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells	59
Tumor microenvironment signaling and therapeutics in cancer progression	57
Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa‐miR‐6887‐3p	57
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells	56
The theory of tumor ecosystem	56
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities	53
Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?	52
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	50
Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study	49
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1	49
S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer	49
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib	45
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates	44
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer	44
Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges	42
Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1‐mediated MAPK signaling	40
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma	40
Lipid metabolism in pancreatic cancer: emerging roles and potential targets	39
Elevated neutrophil extracellular traps by HBV‐mediated S100A9‐TLR4/RAGE‐ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma	39
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma	39
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine	38
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions	36
PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism	36
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis	35
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression	35
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer	34
Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer	34
Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer	34
Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox	32
Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma	31
The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large‐scale cohort study in China	31
Atezolizumab plus bevacizumab versus sorafenib as first‐line treatment for unresectable hepatocellular carcinoma: a cost‐effectiveness analysis	29
The EGFR‐P38 MAPK axis up‐regulates PD‐L1 through miR‐675‐5p and down‐regulates HLA‐ABC via hexokinase‐2 in hepatocellular carcinoma cells	29
N6‐methyladenosine Steers RNA Metabolism and Regulation in Cancer	27
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, r	27
m6A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels	26
CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer	26
KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression	26
Predictions of mortality related to four major cancers in China, 2020 to 2030	26
Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β2‐AR/MACC1 axis	26
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis	25
Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer	25
Metabolic regulation in the immune response to cancer	25
Antibody variable region engineering for improving cancer immunotherapy	25
Crosstalk between IL‐15Rα+tumor‐associated macrophages and breast cancer cells reduces CD8+T cell recruitment	24
Harness the functions of gut microbiome in tumorigenesis for cancer treatment	24

Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients	23
Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis	23
Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma	23
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)	22
Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer	22
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer	22
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment	22
LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma	21
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023	21
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability	21
Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS‐LKB1 co‐mutated lung cancer cells	20
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer	20
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management	20
The role of myeloid‐derived suppressor cells in gastrointestinal cancer	19
YB1 regulates miR‐205/200b‐ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma	19
The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy	19
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study	18
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4	18
Pivotal roles of tumor‐draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy	18
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation	18
Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?	18
Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis‐associated cancer	18
N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway	18
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality	18
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials	18
Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives	18
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop	17
XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)	17
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)	17
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges	17
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer	17
Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden	16
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma	16
MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma	16
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope	15
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy	15
Abscopal effect of stereotactic radiotherapy combined with anti‐PD‐1/PD‐L1 immunotherapy: Mechanisms, clinical efficacy, and issues	15
The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death	15
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A m	14
Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China	14
Roles and implications of mRNA N6‐methyladenosine in cancer	14
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows	14
Dicer‐independent snRNA/snoRNA‐derived nuclear RNA 3 regulates tumor‐associated macrophage function by epigenetically repressing inducible nitric oxide synthase transcription	14
Childhood overweight and risk of obesity‐related adult cancer in men	14
Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells	13
BAALC‐AS1/G3BP2/c‐Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma	13
Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome	13
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82	13
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins	13
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation	13
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity	12
PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression	12
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract	12
Impact of diabetes on promoting the growth of breast cancer	12
Involvement of long non‐coding RNAs in the progression of esophageal cancer	12
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors	12
Bifidobacterium adolescentis orchestrates CD143+ cancer‐associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling‐regulated GAS1	12
Machine learning models for outcome prediction of Chinese uveal melanoma patients: A 15‐year follow‐up study	11
Improved esophageal squamous cell carcinoma screening effectiveness by risk‐stratified endoscopic screening: evidence from high‐risk areas in China	11
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	11
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression	11
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells	11
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy	11
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies	11
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy	10
Physical activity and cancer risk: a dose‐response analysis for the Global Burden of Disease Study 2019	10
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer	10
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas	10
Phospholipase iPLA2β acts as a guardian against ferroptosis	10
Evaluation of renal cancer progression in a mouse model of heart failure	9
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates	9
LncRNA‐CCAT5‐mediated crosstalk between Wnt/β‐Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity	9
The SARS‐CoV‐2 spike protein induces lung cancer migration and invasion in a TLR2‐dependent manner	9
Management of locally advanced non‐small cell lung cancer: State of the art and future directions	9
Immunologic tumor microenvironment modulators for turning cold tumors hot	9
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	8
Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies	8
Cytoplasmic YAP1‐mediated ESCRT‐III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer	8
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment	8
Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy	8

Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C	8
Interactions of Indoleamine 2,3‐dioxygenase‐expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of th	8
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target	8
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer	8
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells	8
Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives	8
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer	8
SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis	7
Development of antibody‐drug conjugates in cancer: Overview and prospects	7
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	7
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma	7
Co‐occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome	7
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress‐driven hepatocellular carcinoma progression	7
Bone marrow metastasis from advanced gastric cancer complicated with disseminated intravascular coagulation: a highly aggressive but manageable disease subtype	7
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial	7
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study	7
Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution	7
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors	7
N6‐methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export	7
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	7
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors	6
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study	6
DNA crosslinking and recombination‐activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia	6
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling	6
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study	6
Cellular metabolism: A key player in cancer ferroptosis	6
A novel histone deacetylase inhibitor exerts promising anti‐breast cancer activity via triggering AIFM1‐dependent programmed necrosis	6
	6
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis	6
Worldwide trends in esophageal cancer survival, by sub‐site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000‐2014 (CONCORD‐3)	6
Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases	6
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis	6
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low‐dose metformin	6
MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response	6
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma	6
Genetic alternations and immune characteristics in patients with small cell lung cancer	6
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia	6
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line	6
Characterization of DNA damage response deficiency in pancreatic cancer patients from China	6
Lipid droplets: could they be involved in cancer growth and cancer–microenvironment communications?	6
Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2	6
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer	6
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis	6
Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade	6
Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance	5
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure	5
Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection	5
Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2−/− acute myeloid leukemia	5
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations	5
All‐trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down‐regulating B7‐H6 expression via c‐Myc signaling	5
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis	5
Metabolon: a novel cellular structure that regulates specific metabolic pathways	5
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter	5
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending	5
Non‐recovery of renal function was correlated with increased mortality in the cancer cohort with septic shock	5
Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors	5
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach	5
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps	5
μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial	5
Lung cancer risk score for ever and never smokers in China	5
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	5
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer	5
Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers	5
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling	5
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity	5
Intrinsic PD‐L1 promotes antitumor activity of CD8+ cytotoxic T lymphocytes via in cis interaction with CD80	4
High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathway	4
Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy	4
Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy	4
SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation	4
Licochalcone A suppresses Sp1 expression with potential anti‐myeloma activity	4
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis	4
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer	4
A serum microRNA signature for enhanced selection of people for lung cancer screening	4
Individualized elective irradiation of the clinically node‐negative neck in definitive radiotherapy for head and neck squamous cell carcinoma	4
N6‐methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer	4
United States oncologists’ clinical preferences regarding modes of medicinal cannabis use	4
Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer	4
High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion	4
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types	4
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors	4
Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment	4
Spatial relationship of tertiary lymphoid structures and tumor‐associated neutrophils in bladder cancer and prognostic potential for anti‐PD‐L1 immunotherapy	4
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence	4
Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma	4
Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer	4
CircBA1 derived from BCR‐ABL fusion gene inhibits cell proliferation in chronic myeloid leukemia	4
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data	4
JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte‐derived leptin	4
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study	4
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients	4
	4
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL3	4
Novel endogenous endoplasmic reticulum transmembrane protein SURF4 suppresses cell death by negatively regulating the STING‐STAT6 axis in myeloid leukemia	4
Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials	3